BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19586829)

  • 1. Cadmium concentration and metallothionein expression in prostate cancer and benign prostatic hyperplasia of humans.
    Lee JD; Wu SM; Lu LY; Yang YT; Jeng SY
    J Formos Med Assoc; 2009 Jul; 108(7):554-9. PubMed ID: 19586829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallothionein expression in human prostate gland.
    Bataineh ZM; Nusier MK
    Saudi Med J; 2003 Nov; 24(11):1246-9. PubMed ID: 14647563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP1A1 gene polymorphism and heavy metal analyses in benign prostatic hyperplasia and prostate cancer: An explorative case-control study.
    Singh V; Madeshiya AK; Ansari NG; Singh MK; Abhishek A
    Urol Oncol; 2023 Aug; 41(8):355.e9-355.e17. PubMed ID: 37277283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metallothionein of prostatic tissues and fluids in rats and humans.
    Suzuki T; Yamanaka H; Tamura Y; Nakajima K; Kanatani K; Kimura M; Otaki N
    Tohoku J Exp Med; 1992 Feb; 166(2):251-7. PubMed ID: 1373527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH.
    Yun SJ; Yan C; Jeong P; Kang HW; Kim YH; Kim EA; Lee OJ; Kim WT; Moon SK; Kim IY; Choi YH; Kim WJ
    Ann Surg Oncol; 2015 Jul; 22(7):2439-45. PubMed ID: 25348783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
    Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M
    J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical study of metallothionein in normal and benign prostatic hyperplasia of human prostate.
    Suzuki T; Umeyama T; Ohma C; Yamanaka H; Suzuki K; Nakajima K; Kimura M
    Prostate; 1991; 19(1):35-42. PubMed ID: 1715081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced expression of metallothionein isoform 3 protein in tumor heterotransplants derived from As+3- and Cd+2-transformed human urothelial cells.
    Zhou XD; Sens MA; Garrett SH; Somji S; Park S; Gurel V; Sens DA
    Toxicol Sci; 2006 Oct; 93(2):322-30. PubMed ID: 16854967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of NKX3.1 expression in prostate cancer tissues and correlation with clinicopathologic features.
    Aslan G; Irer B; Tuna B; Yorukoglu K; Saatcioglu F; Celebi I
    Pathol Res Pract; 2006; 202(2):93-8. PubMed ID: 16413692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of some selected cytokeratins and Ki67 protein in prostatic tumor: can these be used as tumor markers.
    Adisa JO; Egbujo EC; Ibrahim B; Musa B; Madukwe J
    Pan Afr Med J; 2015; 20():46. PubMed ID: 26090004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc and cadmium analysis in human prostate neoplasms.
    Bryś M; Nawrocka AD; Miekoś E; Zydek C; Foksiński M; Barecki A; Krajewska WM
    Biol Trace Elem Res; 1997; 59(1-3):145-52. PubMed ID: 9522056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.
    Engelhardt PF; Seklehner S; Brustmann H; Lusuardi L; Riedl CR
    Scand J Urol; 2015 Apr; 49(2):120-6. PubMed ID: 25363611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
    Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
    Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate.
    Ogunlewe JO; Osegbe DN
    Cancer; 1989 Apr; 63(7):1388-92. PubMed ID: 2465818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc and cadmium concentration in prostatic carcinoma of different histological grading in comparison to normal prostate tissue and adenofibromyomatosis (BPH).
    Feustel A; Wennrich R; Steiniger D; Klauss P
    Urol Res; 1982; 10(6):301-3. PubMed ID: 6186062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].
    Zhou WQ; Sun YH; Yin HL; Zhang ZY; Ge JP; Cheng W; Ma HQ; Wei W; Zhou SG; Ma HH; Gao JP
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):685-9. PubMed ID: 17918704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
    Zhigang Z; Wenlu S
    Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc and cadmium in cell fractions of prostatic cancer tissues of different histological grading in comparison to BPH and normal prostate.
    Feustel A; Wennrich R
    Urol Res; 1984; 12(2):147-50. PubMed ID: 6204433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of thrombospondin-1 in benign prostatic hyperplasia and prostatic intraepithelial neoplasia is decreased in prostate cancer.
    Vallbo C; Wang W; Damber JE
    BJU Int; 2004 Jun; 93(9):1339-43. PubMed ID: 15180634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of air pollution and smoking on placental cadmium, zinc concentration and metallothionein expression.
    Sorkun HC; Bir F; Akbulut M; Divrikli U; Erken G; Demirhan H; Duzcan E; Elci L; Celik I; Yozgatli U
    Toxicology; 2007 Aug; 238(1):15-22. PubMed ID: 17644235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.